You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

capmatinib and spartalizumab

Showing 1 - 25 of 35
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oesophageal Adenocarcinoma, Gastric Adenocarcinoma Trial in France (Capmatinib, Spartalizumab)

Suspended
  • Oesophageal Adenocarcinoma
  • Gastric Adenocarcinoma
  • Besançon, France
  • +6 more
Feb 1, 2023

NSCLC Trial in Worldwide (Capmatinib, Spartalizumab, Docetaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Fayetteville, Arkansas
  • +7 more
Jan 21, 2022

Triple-negative Breast Cancer Trial in Worldwide (LAG525, Spartalizumab, Carboplatin)

Completed
Has Results
  • Triple-negative Breast Cancer
  • Chandler, Arizona
  • +32 more
Jan 27, 2023

Capmatinib vs. Standard of Care for German Adult Locally

Completed
  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring METex14 Mutations
    • Berlin, Germany
    • +9 more
    Mar 22, 2023

    Tabrecta® (Capmatinib) in South Korea

    Not yet recruiting
    • Non-Small-Cell Lung Carcinoma
    • Capmatinib
    • (no location specified)
    Jan 19, 2023

    Carcinoma, Renal Cell Trial in New York (Spartalizumab, Canakinumab)

    Recruiting
    • Carcinoma, Renal Cell
    • New York, New York
      Columbia University Medical Center
    May 6, 2022

    Non Small Cell Lung Cancer Trial in Worldwide (Capmatinib, Nazartinib)

    Terminated
    • Non Small Cell Lung Cancer
    • Boston, Massachusetts
    • +18 more
    Jul 20, 2022

    Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer Trial in San Francisco (Capmatinib, Trametinib)

    Recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • Stage IV Lung Cancer
    • San Francisco, California
      University of California San Francisco
    Aug 15, 2022

    Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID

    Active, not recruiting
    • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 9, 2022

    Glioblastoma Multiforme Trial in Stanford, Baltimore (MBG453)

    Active, not recruiting
    • Glioblastoma Multiforme
    • Stanford, California
    • +1 more
    Nov 22, 2022

    Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta (Siltuximab, Spartalizumab)

    Recruiting
    • Metastatic Pancreatic Adenocarcinoma
    • Stage IV Pancreatic Cancer AJCC v8
    • Siltuximab
    • Spartalizumab
    • Atlanta, Georgia
    • +2 more
    Feb 1, 2022

    NSCLC Trial in Worldwide (Capmatinib, Amivantamab)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Orange, California
    • +40 more
    Aug 3, 2022

    Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, drug, biological)

    Not yet recruiting
    • Recurrent Lung Non-Small Cell Carcinoma
    • Stage IV Lung Cancer AJCC v8
    • Biospecimen Collection
    • +5 more
    • (no location specified)
    Nov 30, 2022

    NSCLC Trial in Japan, Korea, Republic of, Singapore (capmatinib, pemetrexed, cisplatin)

    Terminated
    • Carcinoma, Non-Small-Cell Lung
    • Kashiwa, Chiba, Japan
    • +3 more
    Jan 31, 2023

    MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

    Active, not recruiting
    • MSI-H Colorectal Cancer
    • +30 more
    • Badalona, Barcelona, Spain
    • +9 more
    Oct 24, 2022

    Metastatic Breast Cancer, Breast Cancer Trial in Houston (Neratinib, Capmatinib)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Breast Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 16, 2022

    Advanced Solid Tumors Trial in Worldwide (PDR001)

    Recruiting
    • Advanced Solid Tumors
    • New York, New York
    • +42 more
    Jan 23, 2023

    Non-Small Cell Lung Carcinoma Trial (Capmatinib 150 mg, Capmatinib 200 mg)

    Recruiting
    • Non-Small Cell Lung Carcinoma
    • Capmatinib 150 mg
    • Capmatinib 200 mg
    • Guwahati, Assam, India
    • +7 more
    Dec 19, 2022

    NSCLC Trial in Pittsburgh (Capmatinib)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jan 9, 2023

    Metastatic NSCLC MET Exon 14 Skipping Mutation and Brain

    Completed
    • Metastatic Non-Small Cell Lung Cancer
    • East Hanover, New Jersey
      18 Novartis Investigative Sites in the US
    Dec 29, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Taipei (Ribociclib, Spartalizumab)

    Active, not recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Taipei, Taiwan
      National Taiwan University Hospital
    Apr 19, 2022

    Squamous Cell Anal Carcinoma, Metastatic Squamous Cell Carcinoma Trial in Besançon, Lyon, Montbeliard (Sample collection)

    Recruiting
    • Squamous Cell Anal Carcinoma
    • Metastatic Squamous Cell Carcinoma
    • Sample collection
    • Besançon, France
    • +2 more
    Mar 10, 2022

    NSCLC Trial in United States (capmatinib)

    Recruiting
    • Non-small Cell Lung Cancer
    • La Jolla, California
    • +7 more
    Oct 5, 2022

    NSCLC (NSCLC) Trial in China (Capmatinib)

    Recruiting
    • Non-Small Cell Lung Cancer (NSCLC)
    • Xiamen, Fujian, China
    • +18 more
    Jan 27, 2023

    Malignant Non-small Cell Tumor of Lung Stage IV Trial in Boston (Capmatinib (INC280))

    Completed
    Has Results
    • Malignant Non-small Cell Neoplasm of Lung Stage IV
    • Capmatinib (INC280)
    • Boston, Massachusetts
      Massachusetts General Hospital
    Mar 11, 2022